PURPOSE: This study used ultrasonography (US) to investigate the architectural changes in gastrocnemius muscles (GCM) after botulinum toxin injection (BoNT-A) in children with cerebral palsy (CP). MATERIALS AND METHODS: Thirteen children with CP who received a BoNT-A injection into their GCM to treat equinus were recruited (9 males and 4 females). Architectural changes in both the medial and lateral heads of the GCM from a total of 20 legs were assessed using B-mode, real-time US. Muscle thickness (MT), fascicle length (FL), and fascicle angle (FA) were measured over the middle of the muscle belly in both a resting and neutral ankle position. Measures at 1 and 3 months after the injection were compared with baseline data taken before the in...
PURPOSE: To investigate the effect of intramuscular Botulinum toxin type A (BoNT-A) injection on gai...
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical in...
A recent study claimed that botulinum toxin A (BTX-A) injection into the calf muscle of cerebral pal...
AIM: With evidence for an atrophic effect of botulinum toxin type A (BoNT-A) documented in typically...
Aim: This study aimed to track alterations in muscle volume for 6 months in children with cerebral p...
Aim: This cross-sectional investigation evaluated whether recurrent botulinum neurotoxin A (BoNT-A) ...
AIM: This cross-sectional investigation evaluated whether recurrent botulinum neurotoxin A (BoNT-A) ...
Introduction: Botulinum toxin A (BoNTA) is routine treatment for hypertonicity in children with cere...
Introduction: Botulinum toxin A ( BoNTA ) is routine treatment for hypertonicity in children with ce...
Background: Muscles from patients with cerebral palsy (CP) are often spastic and form contractures t...
OBJECTIVE: To investigate the benefit of botulinum toxin type A injection into the ankle plantarflex...
Botulinum NeuroToxin-A (BoNT-A) injections to the medial gastrocnemius (MG) and lower-leg casts are ...
Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity treatment i...
Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity treatment i...
∙ The authors have no financial conflicts of interest. © Copyright: Yonsei University College of Med...
PURPOSE: To investigate the effect of intramuscular Botulinum toxin type A (BoNT-A) injection on gai...
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical in...
A recent study claimed that botulinum toxin A (BTX-A) injection into the calf muscle of cerebral pal...
AIM: With evidence for an atrophic effect of botulinum toxin type A (BoNT-A) documented in typically...
Aim: This study aimed to track alterations in muscle volume for 6 months in children with cerebral p...
Aim: This cross-sectional investigation evaluated whether recurrent botulinum neurotoxin A (BoNT-A) ...
AIM: This cross-sectional investigation evaluated whether recurrent botulinum neurotoxin A (BoNT-A) ...
Introduction: Botulinum toxin A (BoNTA) is routine treatment for hypertonicity in children with cere...
Introduction: Botulinum toxin A ( BoNTA ) is routine treatment for hypertonicity in children with ce...
Background: Muscles from patients with cerebral palsy (CP) are often spastic and form contractures t...
OBJECTIVE: To investigate the benefit of botulinum toxin type A injection into the ankle plantarflex...
Botulinum NeuroToxin-A (BoNT-A) injections to the medial gastrocnemius (MG) and lower-leg casts are ...
Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity treatment i...
Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity treatment i...
∙ The authors have no financial conflicts of interest. © Copyright: Yonsei University College of Med...
PURPOSE: To investigate the effect of intramuscular Botulinum toxin type A (BoNT-A) injection on gai...
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical in...
A recent study claimed that botulinum toxin A (BTX-A) injection into the calf muscle of cerebral pal...